This document summarizes findings from the Heart Outcomes Prevention Evaluation (HOPE) study regarding the relationship between infections and cardiovascular events. The HOPE study analyzed antibodies to four pathogens (Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, hepatitis A virus) in over 3,000 patients over 4.5 years. While C. pneumoniae and H. pylori antibodies showed no significant association, cytomegalovirus antibodies were mildly correlated with increased cardiovascular risk. Having a higher "total pathogen score" based on levels of antibodies to all four pathogens predicted a higher risk of cardiovascular events compared to having none or just one infection.